Abstract
Caffeine has been previously reported to enhance the lethal potential of many DNA-damaging agents in rodent cells1–5. This effect has most commonly been ascribed to the binding of caffeine to single-stranded DNA6, and the resulting inhibition of post-replication repair7–10, which is associated with the synthesis of abnormally small nascent DNA fragments7,11–13. However, certain aspects of this theory remain unclear: (1) why does the addition of caffeine to damaged cells elevate the level of DNA synthesis when it supposedly blocks post-replication repair10,14, and (2) as pointed out by Cleaver15, why does caffeine continue to exert its synergistic lethal effects until completion of the S phase16,17, even though the size of newly synthesized DNA seems normal much earlier18–20? The present studies with nitrogen mustard (HN2) fail to demonstrate any effect of non-lethal concentrations of methylated xanthines (MXs) on removal of DNA damage or post-replication repair in conditions producing synergistic lethal effects. We demonstrate an influence by MXs on initiation of DNA synthesis in damaged replicons, and propose that this effect is primarily responsible for the synergistic lethal properties of these drugs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rauth, A. M. Radiat. Res. 31, 121–138 (1967).
Rauth, A. M., Barton, C. & Lee, C. P. Y. Cancer Res. 30, 2724–2729 (1970).
Walker, I. G. & Reid, B. D. Mutat. Res. 12, 101–104 (1971).
Roberts, J. J., Sturrock, J. E. & Ward, K. N. Mutat. Res. 26, 129–143 (1974).
Busse, P. M., Bose, S. K., Jones, R. W. & Tolmach, L. J. Radiat. Res. 71, 666–677 (1977).
Ts'o, P. O. P. & Lu, P. Proc. natn. Acad. Sci. U.S.A. 51, 17–24 (1964).
Cleaver, J. E. & Thomas, G. H. Biochem. biophys. Res. Commun. 36, 203–208 (1969).
Fujiwara, Y. Expl Cell Res. 75, 483–489 (1972).
Buhl, S. N. & Regan, J. D. Biophys. J. 14, 519–527 (1974).
Lehmann, A. R. & Kirk-Bell, S. Mutat. Res. 26, 73–82 (1974).
Rupp, W. D. et al. Brookhaven natn. Lab. Publ. No. 50203, 1–11 (1969).
Lehmann, A. R. J. molec. Biol. 66, 319–337 (1972).
Buhl, S. N., Setlow, R. B. & Regan, J. D. Int. J. Radiat. Biol. 22, 417–424 (1972).
Van Den Berg, H. W. & Roberts, J. J. Chemico-Biol. Interact. 12, 375–390 (1976).
Cleaver, J. E. Biochim. biophys. Acta 516, 489–516 (1978).
Roberts, J. J. & Ward, K. N. Chemico-Biol. Interact. 7, 241–264 (1973).
Domon, J. & Rauth, A. M. Radiat. Res. 39, 207–214 (1969).
Meyn, R. E. & Humphrey, R. M. Biophys. J. 11, 295–301 (1971).
Lehmann, A. R. Eur. J. Biochem. 31, 438–445 (1972).
Buhl, S. N., Setlow, R. B. & Regan, J. D. Biophys. J. 13, 1265–1275 (1973).
Wilkinson, R., Kiefer, J. & Nias, A. H. W. Mutat. Res. 10, 67–72 (1970).
Maher, V. M., Ouellette, L. M., Mittlestat, M. & McCormick, J. J. Nature 258, 760–763 (1975).
Schroy, C. B. & Todd, P. Mutat. Res. 33, 347–355 (1975).
Busse, P. M., Bose, S. K., Jones, R. W. & Tolmach, L. J. Radiat. Res. 76, 292–307 (1978).
Fogh, J. & Trempe, G. in Human Tumor Cells In-Vitro (ed. Fogh, J.) 115–174 (Plenum, New York, 1975).
Lawley, P. D. Prog. Nucleic Acid Res. 5, 89–131 (1966).
Kohn, K. W., Erickson, L. C., Ewig, R. A. G. & Friedman, C. A. Biochemistry 15, 4629–4637 (1976).
Ewig, A. G. & Kohn, K. W. Cancer Res. 37, 2114–2122 (1977).
Fornace, A. J. Jr, Little, J. B. & Weischselbaum, R. R. Biochim. biophys. Acta 561, 99–109 (1979).
Kohn, K. W., Erickson, L. C., Ewig, R. A. G. & Iqbal, Z. M. Biochemistry 13, 4134–4139 (1974).
Makino, F. & Okada, S. Mutat. Res. 23, 387–394 (1974).
Tolmach, L. J., Jones, R. W. & Busse, P. M. Radiat. Res. 71, 653–665 (1977).
Painter, R. B. & Young, B. R. Radiat. Res. 64, 648–656 (1975).
Walters, R. A. & Hildebrand, C. E. Biochem. biophys. Res. Commun. 65, 265–271 (1975).
Povirk, L. F. J. molec. Biol. 114, 141–151 (1977).
Painter, R. B. Mutat. Res. 42, 299–304 (1977).
Lehmann, A. R. Biophys. J. 12, 1316–1325 (1972).
Ehmann, U. K., Gehring, U. & Tomkins, G. M. Biochim. biophys. Acta 447, 133–138 (1976).
Blumenthal, A. B., Kriegstein, H. J. & Hogness, D. S. Cold Spring Harb. Symp. quant. Biol. 38, 205–223 (1973).
Konze-Thomas, B., Levinson, J. W., Maher, M. & McCormick, J. J. Biophys. J. 28, 315–325 (1979).
Fraval, H. N. A. & Roberts, J. J. Cancer Res. 39, 1793–1797 (1979).
Hagan, M. P. & Elkind, M. M. Biophys. J. 27, 75–85 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Murnane, J., Byfield, J., Ward, J. et al. Effects of methylated xanthines on mammalian cells treated with bifunctional alkylating agents. Nature 285, 326–329 (1980). https://doi.org/10.1038/285326a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/285326a0
This article is cited by
-
Pharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel
BMC Cancer (2010)
-
Caffeine inhibits homology-directed repair of I-SceI-induced DNA double-strand breaks
Oncogene (2004)
-
Homologous recombination as a potential target for caffeine radiosensitization in mammalian cells: reduced caffeine radiosensitization in XRCC2 and XRCC3 mutants
Oncogene (2000)
-
Cell cycle regulation in response to DNA damage in mammalian cells: A historical perspective
Cancer and Metastasis Reviews (1995)
-
Interaction between cytostatics and nutrients
Medical Oncology and Tumor Pharmacotherapy (1991)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.